Filing metadata

Accession number
0001628280-21-012468
Form type
Form 3
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Jun 17, 2021
Reporting period
Jun 14, 2021
Description
Initial ownership

Explore SEC Filings Hub